CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Financial comparisons Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178.08 USD | -6.34% |
|
-6.16% | -3.53% |
| 01-14 | Charles River Seeks Strategic Acquisitions | CI |
| 01-14 | Charles River Laboratories International, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 02:15 PM |
Main competitors
| Revenues | Net margin | Operating Margin | ROE | ROA | Leverage (Debt/EBITDA) | ||
|---|---|---|---|---|---|---|---|
| 4,129,409,000.00 | +11.49% | +20.31% | 16.7x | 6.95x | 2.34x | ||
| 7,347,005,742.41 | +9.74% | +13.98% | 6.52x | 3.82x | 0.46x | ||
| 14,984,000,000.00 | +9.06% | +20.36% | 32.01x | 5.22x | 3.45x | ||
| 1,491,411,694.57 | +24.61% | +29.93% | 5.07x | 4.31x | 1.46x | ||
| 8,120,176,000.00 | +7.54% | +19.31% | 6.9x | 3.58x | 2x | ||
| 2,327,500,000.00 | +42.31% | +50.91% | 18.27x | 14.91x | -1.85x | ||
| 6,848,000,000.00 | -68.84% | -61.90% | -28.59x | -21.29x | 2.38x | ||
| 1,159,060,000.00 | +14.50% | +31.94% | 14.11x | 6.29x | 0.4x | ||
| 1,885,842,000.00 | +15.00% | +17.94% | 59.83x | 18.8x | -0.29x | ||
| 1,965,311,000.00 | +17.37% | +26.90% | 4.69x | 2.75x | 0.69x | ||
| 11,580,000.00 | -3,768.28% | -4,207.12% | -34.76x | -30.38x | 3.85x | ||
| 249,380,000.00 | -203.30% | -194.99% | -157.13x | - | 0.99x | ||
| 788,000,000.00 | -46.45% | -44.80% | -76.34x | -13.26x | 3.21x | ||
| 1,007,221,153.72 | +27.44% | +35.35% | 9.95x | 7.09x | -1.51x | ||
| 1,573,842,397.46 | +13.88% | +14.92% | 13.86x | 6.82x | 1.36x | ||
| 531,822,000.00 | -40.26% | - | - | - | - | ||
| 311,078,303.93 | +1.04% | +10.29% | 34.35x | 12.03x | -1.95x | ||
| 1,663,405,000.00 | +21.39% | +24.90% | 21.69x | 11.88x | -1.07x | ||
| 631,464,041.56 | +19.38% | +22.41% | 9x | - | -1.79x | ||
| Average | 3,001,342,543.88 | -204.86% | -231.63% | -2.44x | 2.47x | 0.79x | |
| Weighted average by Cap. | 5,273,801,992.21 | -111.96% | -119.66% | 5.71x | 3.30x | 1.16x |
- Stock Market
- Equities
- CRL Stock
- Sector Charles River Laboratories International, Inc.
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition